LPA and type 2 diabetes mellitus: Overall, our findings contribute to the growing body of evidence linking Lp(a) to ASCVD risk in T2D patients with microvascular complications, and they underscore the importance of considering the unique characteristics of patient cohorts when interpreting the impact of Lp(a) on cardiovascular outcomes.